Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, has entered into a ...

BioMarin has entered into a definitive agreement to acquire Inozyme Pharma Inc. for a total consideration of approximately ...

Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk. In the meantime, a search for Jørgensen’s successor is ongoing. Novo Nordisk says the leadership transition is “made in ...

Manufacturing company groninger is investing over $14 million in new headquarters at its U.S. location in Charlotte, N.C.

Aptamer Group plc has announced two new development contracts for its Optimer binders and a licensing heads of terms ...

Septerna, Novo Nordisk partner to discover, develop and commercialize oral small molecule medicines for cardiometabolic ...

The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.

FAMAR Group, a CDMO, has signed an agreement to acquire a sterile production site in Homburg, Germany, from MiP Pharma.

What’s at stake in the face the enforcement deadlines and how exception management lays the groundwork for future-ready ...